지투지바이오

456160KOSDAQ의약품 제조업

50.8 / 100

Reference Date: 2026-06-10

Financial Score17.5 / 40

News Sentiment20.3 / 25

Momentum3.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PBR raises overvaluation concerns. Plunged 38.6% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

GTJ Bio is a leading company in microsphere technology for prolonged-release pharmaceuticals, utilizing its InnoLAMP platform to develop drugs for various diseases and offering CDO/CDMO services. Its key products, including GB-7001, GB-5001, and GB-6002, are undergoing clinical trials in collaboration with global pharmaceutical companies, supported by patented technology and large-scale production capabilities that create high entry barriers.

Number of Employees

48people

Average Salary

125.4M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 11.934.0Point

PBR

13.78Industry Average 0.890.0Point

15.5x industry avg (risky)

ROE

—Industry Average 4.013.5Point

Debt Ratio

3.69Industry Average 12.438.0Point

Half of industry avg (excellent)

Trend 2024~20252.0 / 10 points

Revenue Growth Rate

0.0 / 3

Avg ▼45.0% (1-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼13.4% (1-year basis)

ROE Trend

2.0 / 4

Detailed News Sentiment

8 totalPositive 7Neutral 1Negative 0Average Sentiment Score 81.2

Positive
지투지바이오, 이중·삼중작용 비만약 '월 1회 제형' 가능성 입증
지투지바이오가 ADA 학회에서 장기지속형 주사제 개발 가능성을 입증하며 비만치료제 시장에서의 혁신적 위치를 강화했다.
Positive
지투지바이오, 美당뇨병학회서 한달 제형 비만약 전임상 데이터 공개
지투지바이오가 미국 당뇨병학회에서 한 달 제형 비만약의 전임상 데이터를 공개하며 긍정적인 연구 결과를 발표했다.
Positive
지투지바이오, ADA서 차세대 비만약 '이중·삼중 작용제' 데이터 공...
지투지바이오가 ADA에서 이중·삼중 작용제의 장기지속형 주사제 전임상 데이터를 공개하며 비만치료 분야에서의 혁신적 가능성을 보여주었다.

Detailed Momentum

52-week position1.0Point

Near 52w low (19%, downtrend)

Current 48,350Won52-week high 118,80052-week low 31,283

1-month return0.0Point

1m -38.56% (strong drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

10 totalPositive 0Neutral 10Negative 0

Neutral[기재정정]주식등의대량보유상황보고서(일반)2026-06-05
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-05
Neutral주식등의대량보유상황보고서(일반)2026-06-05
Neutral[기재정정]주식등의대량보유상황보고서(일반)2026-06-05
Neutral[기재정정]주식등의대량보유상황보고서(일반)2026-06-05